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Type A aortic dissection (TAAD) is a severe cardiovascular disease with high mortality rates. Current 
evidence suggests inflammation as the main mechanism of its complex pathophysiology. Accordingly, 
in this study the eventual presence of inflammatory cells in aorta specimens and any contribution of 
these cells in both apoptosis and metalloproteinase levels were assessed. The potential relationship 
between plasma inflammatory molecules and TAAD was also detected. In addition, implication in 
TAAD susceptibility of ten common and functional single nucleotide polymorphisms (SNP)s of six 
candidate genes (CCR5, TLR4, ACE, eNOs, MMP-9 and -2) was determined. Thus, histo-pathological 
and immunoistochemical aorta examination, TUNEL testing, genotyping of ten SNPs were performed. 
Levels of plasma inflammatory molecules were also determined using ELISA technique. A significant 
inflammatory infiltrate was observed in the examined aortas. Consistent with these data, significantly 
higher plasma levels of systemic inflammatory mediators characterized the cases. In addition, a high 
risk genotype significantly associated with TAAD susceptibility was identified. Thus, inflammation 
producing MMPs, cytokines and death mediators seem to be the shared pathological mechanism for 
TAAD in the population examined.  
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LETTER TO THE EDITOR
Aortic dissection (AD) is an age-dependent life-
threatening cardiovascular disease, with severe 
morbidity and mortality (1, 2). It occurs in the sixth 
and seventh decades of life with 2,000 new cases each 
year in North America and 3,000 in Europe (3). AD 
is becoming an increasing medical problem because 
of both a high prevalence of underlying diseases (i.e. 
hypertension) and augmenting ageing in Western 
populations (3, 4). Ageing is associated with medial 
degeneration and is an important AD risk factor 
(5, 6). Hypertension represents the most common 
predisposing factor for AD in elderly subjects (2, 
7). In fact, more than 70% of AD patients show 
hypertension (1, 2, 7). However, other risk factors 
contribute to AD onset, i.e. smoking, dyslipidemia, 
cocaine use, iatrogenic injury and accidents (1-
3, 7). Thus, AD is a complex disease with several 
aetiological risk factors, such as environmental 
factors and lifestyle, having a strong role in its 
pathogenesis. Current evidence also suggests a key 
involvement of different genetic factors (1-3, 8). 
However, its pathophysiology remains unclear (1-3). 
A large number of speculations have been proposed. 
Overall impression is based on an initiating event of 
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AD onset, the intimal tear, determined by subintima 
or media necrosis and apoptosis. It implies both 
separation of the aortic wall layers and a rapid 
propagation of AD. This condition may determine 
the reduction of perfusion of numerous organs with 
devastating complications (1-3). Recent evidence 
suggests inflammation as the principal mechanism of 
aorta AD medial degeneration (6, 9-12). In particular, 
it has been demonstrated that inflammatory cells, 
such as lymphocytes and macrophages, not only 
increase the expression of proteases and cell 
adhesion molecules, but also release reactive oxygen 
species. Thus, they contribute to the apoptosis 
of vascular smooth muscle cells (VSMCs) in the 
aortic artery, and finally lead to medial degradation 
(6, 9-12). Furthermore, this condition determines 
increases in systemic inflammatory molecules [i.e. 
Interleukin-6 (IL-6) and tumor necrosis factor-α 
(TNF-α), metalloproteinase (MMP)s, C-reactive 
protein (CRP)], as detected in individuals with aortic 
dissection (6, 9-12). 
Based on these observations, in this study the 
eventual presence of inflammatory cells in aorta 
specimens and any contribution of these cells in 
apoptosis, MMP-9 level and aorta wall alterations were 
assessed in aorta samples from patients affected by 
type A AD (TAAD). The relationship between levels 
of plasma inflammatory molecules and TAAD was 
also detected. Furthermore,  the implication was also 
determined in TAAD susceptibility of ten common 
and functional single nucleotide polymorphisms 
(SNP)s of six candidate genes (CCR5, TLR4, 
ACE, eNOs, MMP-9 and -2) involved in innate and 
inflammatory responses, hypertension, production 
of reactive oxygen species and MMP synthesis (13). 
Identification of a genetic risk profile useful both in 
diagnostics  and to develop more targeted treatment 
for individual patients and to suggest additional or 
alternative therapeutic strategies for both prevention 
and treatment of TAAD was also assessed. This 
might permit to identify potential biomarkers as risk 
factors for early detection of this ailment. 
The study included 18 TAAD patients [13 
men (72%) and 5 (28%) women; mean age: 
66.16±9.87] from Western Sicily enrolled at time 
of their admission to the Cardiac Surgery Unit of 
Palermo University Hospital. TAAD was diagnosed 
through imaging techniques. For patient selection, 
histopathological analyses and exclusion criteria 
for syndromic and familial forms (e.g. Marfan 
and Ehlers-Danlos syndromes) and autoimmune 
connective tissue disorders were utilised. Medical 
histories pertinent to this clinical condition were 
obtained from the patients’ medical records. Thus, 
demographic and clinical features, co-morbidity 
conditions and pharmacological treatments were 
collected (Table I). The control group consisted of 
128 subjects [61 (47%) men and 67 (53%) women; 
mean age: 61.08±5.83 years] belonging to same 
ethnic group as the patients, since their parents 
and grandparents were born in Western Sicily. 
Thus, a very homogenous population was enrolled. 
Controls were in good health according to their 
clinical history and blood tests (complete blood cell 
count, erythrocyte sedimentation rate, glucose, urea 
nitrogen, creatinine, electrolytes, C reactive protein, 
liver function tests, iron, and proteins) (Table I). Their 
demographic and clinical features, co-morbidity 
conditions and pharmacological treatments were 
collected (Table I). Furthermore, echocardiography 
imaging examinations confirmed absence of any aorta 
wall histopatological abnormalities in all controls. 
In order to detect histopathological abnormalities, 
control ascending aortas from 20 individuals (18 
men and 2 women, mean age: 66.9±11.57) who had 
died from causes unrelated to aortic disease and with 
no sepsis at death time, as confirmed by autopsy, 
were also used (Table I). 
Our study received approval from the local 
ethics committee and all participants gave their 
informed consent. Data were encoded to ensure 
patient and control protection. All measurements 
were performed without knowledge of the nature of 
material. 
Aorta specimens, control aorta tissues, DNA 
samples of both the case subjects and 128 controls 
were obtained as described in the recent study 
by Pisano et al. (13). Furthermore, procedures, 
criteria, definitions and grading systems for tissue 
sample collection, staining, histopathological 
and immunohistochemical assessment, Terminal 
deoxynucleotidyl transferase dUTP Nick End 
Labeling (TUNEL) testing, semi-quantitative MMP-
9 evaluation and genotyping were performed as 
described in detail in the study of Pisano et al. (13). 
Information on the ten SNPs analysed was acquired 
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Table I. Demographic and clinical characteristics, comorbodity conditions and pharmacological 
treatment of 18 patients affected by TAAD, 128 control subjects and 20 aorta controls.
     Variables Patients   Controls  Aorta Controls  
  N=18  N=128 N=20
Demographic characteristics     
  Age, mean (SD)   66.2 (9.9)   61.1(5,8) 69.9 (11.57) 
  Body mass index, mean (SD) 29.2 (4.9)   27.9(2.9)  25.2 (1.3) 
       
Diameter Size and dissection  location     
  Size (mm), mean (SD)   47.6 (6.3)   0 (0)  0(0) 
  Location, No (%):     
  Ascending aorta   6 (33)     
  Aortic bulb  1 (6)   
Ascending aorta and Aortic bulb   11 (61)     
       
Comorbidity conditions, No (%)     
  Aortic Aneurysm  Familiarity   0 (0)    0 (0) 0 (0) 
  Cardiovascular Ischemic  Familiarity     3 (17)   34 (27) 1(5) 
  Smoke   7 (39)   66 (51) 3(15%) 
  Hypertension   9 (50)   40 (31) 1(5) 
  Dislipidemy   3 (17)   20 (16)  0(0) 
  Diabetes mellitus   3 (17)   16 (13)  0(0) 
  Renal failure   1 (6)    0(0)  0(0) 
  Bicuspid aortic valve disease   0 (0)    0(0)  0(0) 
  Aortic valve pathology, No (%):           
  Normal  10 (56)  0 (0) 0 (0) 
  Prolapse  6 (33)  0 (0) 0 (0) 
  Vascular calcium fibrosis   2 (11)   0 (0) 0 (0) 
  Aortic valve disfunction, No (%):       
  Normal  4 (22)  0 (0) 0 (0) 
  Faint incontinence  4 (22)  0 (0) 0 (0) 
  Moderate incontinence  3 (17)  0 (0) 0 (0) 
  Severe incontinence  7 (39)  0 (0) 0 (0) 
  Faint stenosis  0 (0)  0 (0) 0 (0) 
  Moderate stenosis  0 (0)  0 (0) 0 (0) 
  Severe stenosis   0 (0)   0 (0) 0 (0) 
  Atherosclerosis coronary sindrome  1 (6)   0 (0)                 0 (0) 
       
Drugs, No (%)    0 (0) 
  Beta blockers   2 (11)   0 (0) 0 (0) 
  Central alpha-adrenergic agonists  0 (0)  0 (0) 0 (0) 
  Sartans   0 (0)   0 (0) 0 (0) 
  Calcium-channel blockers 2 (11)   21 (16)  0 (0) 
  ACE inhibitors   2 (11)   0 (0) 0 (0) 
  Antidiabetic drugs   1 (6)   0 (0) 0 (0) 
  Antiaggregant drugs   2 (11)   0 (0) 0 (0) 
  Anti-dislipidemic drugs 2 (11)   40 (31)  0 (0) 
  Diuretics   2 (11)   0 (0) 0 (0) 
Table I. Demographic and clinical characteristics, comorbodity conditions and pharmacological treatment of 18 patients 
affected by TAAD, 128 control subjects and 20 aorta controls.
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using Pearson c2 test. Significant relationships 
between quantitative variables were assessed by 
Wilcoxon rank sum test. Furthermore, Odds Ratios 
(OR) with 95% Confidence Intervals (CI) and their 
significance were also calculated. Quantitative 
values of plasma inflammatory molecules were 
expressed as mean± SD. Categorical variables were 
compared by chi-square test or Fisher’s exact test. 
Correlations were assessed using Spearman’s rank 
correlation. A P< 0.05 was considered statistically 
significant. Allele and genotype frequencies were 
evaluated by gene count. Data were tested for 
goodness of fit between observed and expected 
genotype frequencies according to Hardy-Weinberg 
equilibrium, by c2 tests. Significant differences 
in frequencies among groups were calculated by 
using c2 test and appropriate tables (3x2, 2x2 and 
3x3 tables, etc. where appropriate). Significant 
relationship between genetic variables and pathology 
risk was analysed using quasi-likely hood binomial 
models (13).
As reported in Fig. I, a significantly higher 
infiltrate of lymphocytes and macrophages in 
from db SNP NCBI and reported in detail in the 
same study. Furthermore, plasma samples were also 
collected from all patients and controls, in a fasting 
state (more than 8 h without food administration 
from onset). From patients who underwent surgical 
treatment, blood samples were collected before 
surgery. Plasma samples were obtained from venous 
blood EDTA samples after a centrifugation of 3500 
rpm at 4°C for 15 min immediately after collection 
and then stored at −80°C for further analysis. Plasma 
IL-6, TNF-α, Interferon (IFN)-g, MMP-2 and 
MMP-9 were measured by using ELISA technique, 
with the R&D Systems (Minneapolis, MN, USA), 
according to the manufacturer's instructions and our 
previous study (17). CRP was determined by a high-
sensitivity assay using a BN II nephelometer (Dade 
Behring, Marburg, Germany). Detection limits were 
0.7 pg/ml, 0.5 pg/ml, 0.8 pg/ml, 0.154 ng/ml, 0.156 
ng/ml and 0.17 mg/l for IL-6, TNF-α, IFN-g, MMP-
2, MMP-9 and CRP, respectively. 
Statistical analysis was performed by using 
appropriate tests. Precisely, significant differences 
between qualitative variables were calculated by 
Fig. 1. Morphometric quantization of T and B lymphocytes, T-cell subpopulations and macrophages in tissue samples of 
the control aortas and patients with TAAD and normal aorta TAAD areas. CD3, CD4, CD8, CD20 and CD68 positive 
cells in media and aventitia in 10 contiguous high-power fields (magnification 400x) were counted by two independent 
observers. Significant increased amounts of CD3+CD4+CD8+CD68+CD20+ cells were observed (p<0.0001, by ANOVA 
test).
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considerable in the vasa vasorum of adventitia from 
the aorta patient samples. In contrast, a very small 
infiltrate of these cells was observed in control 
aortas, which appears to be less significant in respect 
to that found in normal aorta TAAD areas. CD20+ 
tissue aorta wall samples from TAAD patients 
compared with both control aortas and normal areas 
from the same TAAD tissues was evidenced by 
immunoistochemical investigation. Interestingly, the 
infiltration of inflammatory cells was particularly 
Fig. 2. Aorta wall abnormalities in tissue aorta samples. A) Elastic fragmentation, medio-necrosis, cystic necrosis, medial 
fibrosis essentially of grade II and III were found. B) Focal and plurifocal apoptosis of VSCM cells were also found in all 
tissue aorta samples from patients. In addition, moderate and elevated MMP-9 amounts were observed in 2 and 14 cases 
respectively, and faint quantity in only 2 cases.
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medial fibrosis essentially of grade II and III were 
observed (Fig. 2 A). Focal and plurifocal apoptosis 
of media VSCM cells was essentially assessed in all 
tissue aorta samples from patients and control aortas. 
The MMP-9 semi-quantification also evidenced 
moderate and elevated MMP-9 amounts in 2 and 
14 cases and faint only in 2 cases, respectively, as 
reported in Fig. 2 B. In addition, the evaluation of 
correlations between tissue aorta wall alterations 
and some risk factors (such as hypertension, body 
mass index, smoking and age) demonstrated positive 
cell infiltrate was less represented in three groups, 
even if significant differences were observed by 
comparing the three cohort tissues. Immunostaining 
with CD68 antibody also indicated that macrophages 
were prevalently present in aortas from TAAD 
patients in respect to control aortas and normal areas 
from the same TAAD tissues. 
Different microscopic aorta wall abnormalities 
were also found in aorta samples from 18 TAAD 
patients and control aorta tissues. In particular, elastic 
fragmentation, medio-necrosis, cystic necrosis, 
Table II. Genotype distributions and allele frequencies of -786 eNOs, D/I ACE, -735C/T MMP-2, -
1562C/T SNPs in 18 patients and 128 matched controls [2x2 comparisons between the different 
groups with odd ratio (OR) and 95% confidence interval].
Candidate
genes
Reference SNP 
number
Candidate SNPs Patients 
(n=18)
Matched 
controls
(N=128)
P
(3x2, 2x2 
table)
OR  (95% CI) 
eNOS rs2070744 -786T/T 10             55% 81               63% 
-786T/C 3               17 % 42               33% 
 -786C/C 5                28%  5                  4% 
 -786T 23              64% 204             80% 
 -786C 13              36% 52               20% 
0.006
0.03 2.6 (2.1-3.95) 
p=0.03
ACE   rs1799752 I/I 2               11%   70             55% 
 D/I 1                  5% 1                  1% 
 D/D 15              84% 57               44% 
 I  5             14% 141             55% 
 D  31            86% 115             45% 
0.001
0.000008 7.6 (2.8-20.1) 
p<0.0001
MMP2  ( rs 2285053) -735C/C 13             72% 123             96% 
  -735C/T 4                22% 5                   4% 
  -735T/T 1                  6% 0                   0% 
  -735C 30             83% 251             98% 
  -735T 6                17% 5                  2% 
                             
     0.0002              
                                
       
                            10.4 (2.8-30.1) 
    0.0001                   p<0.0007            
                    
MMP-9 (rs3918242) -1562C/C 10              55% 116             90% 
  -1562C/T 5                28%  9                  8% 
  -1562T/T 3               17%  3                  2% 
  -1562C 25              70% 241             94% 
  -1562T 11              30% 15                 6% 
   0.0001 
 0.000005 
     
16.4 (3.4-28-9) 
        p<0.00001 
Table II. Genotype distributions and llele frequen i s of -786 eNOs, D/I ACE, -735C/T MMP-2, -1562C/T SNPs in 
18 patients and 128 matched controls [2x2 c mparisons between the different groups with odd ratio (OR) and 95% 
confidence interval].
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Consistent with histological, immunoistochemical 
and genetic data, significant differences in IL-6, 
TNF-α, IFN-g, CRP, MMP-2 and-9 plasma levels 
were detected between TAAD patients and controls 
(12.66±2.1 vs 3.1±0.99, p<0.001; 16.78±1.2 vs 
7.1±2.2, p<0.0001; 12.13±1.7 vs 2.1±0.5 p<0.0001; 
14.66±3.2 vs 4.6±1.67, p<0.0001; 56.8±3.8 vs 
12.54±1.6, p<0.0001; and 59.7±3.7 vs 11.7±2.6, 
p<0.0001, respectively). 
The results of this study indicated that 
inflammatory cellular infiltration characterizes 
the medial degeneration of aorta wall from aorta 
samples of hypertensive and old TAAD patients 
examined. It  was distributed and mainly observed 
in the walls of the vasa vasorum of adventitia, 
suggesting the possible migration of inflammatory 
cells from these blood vessels into the aorta media. 
Other studies demonstrated analogous data (6, 9-12). 
In addition, focal and plurifocal apoptosis of media 
VSMC cells were also detected in all tissue aorta 
samples from patients compared with control aortas. 
Thus, apoptotic death should seem to contribute 
to the reduction of cellularity and impaired matrix 
homeostasis. On the other hand, elevated MMP-9 
amounts and elastic fragmentation, medionecrosis, 
cystic necrosis, medial fibrosis essentially of grade 
II and III were also detected in the major number 
of aorta samples from patients than control aortas. 
Positive correlations between these aorta alterations 
and hypertension were also detected.  Based on these 
data, we likely suppose a key role of inflammation 
in determining medial degeneration by affecting 
primarily components of extracellular matrix and 
media VSCM cells. Consistent with these data, 
significant higher plasma levels of MMP-2 and MMP-
9, CRP, IL-6, TNF-α and INF-g were also observed 
in TAAD patients than in controls. In addition, the 
significant levels of INF-g and CD4+ and CD8+cells 
led us to suppose that TAAD pathogenesis may be 
prevalently characterized by Th1immune responses. 
Furthermore, we also highlighted a key of some 
genetic variants (-786T/C eNOs, D/IACE, -1562 C/T 
MMP-9, -735C/T MMP-2 SNPs) of eNOs, ACE, 
MMP-9 and -2 genes in TAAD susceptibility. These 
SNPs are well known for their capacity to modulate 
local and systemic inflammatory degree, tissue 
injury, hypertension and vascular matrix homeostasis 
(13-17). In addition, a higher frequency of this risk 
correlations. In particular, positive correlations were 
detected between inflammatory infiltrate, elastic 
fragmentation, apoptosis and hypertension (r=0.497, 
p=0.0001, n=18 for inflammatory infiltrate; r=0.267, 
p=0.03 n=18 for elastic fragmentation; r=0.342, 
p=0.006, n=18 for apoptosis).  
As shown in Table II, significant differences both 
in genotype distributions and allele frequencies were 
assessed only for  -786T/C eNOs, D/I ACE, -735C/T 
MMP-2, -1562 C/T MMP-9 SNPs. In addition, using 
quasi-hood binomial statistical models we found 
that D/D ACE and -1562T/T MMP-9 genotypes are 
independent risk factors for TAAD (p=0.001). In 
contrast, no significant differences were observed 
either in genotype distribution or allele frequencies 
of +896A/G TLR-4 SNP and Δ32CCR5 deletion 
between patients and controls, even if a trend was 
observed for +896A/G TLR4 SNP (p=0.059 data 
not shown). Furthermore, we examined the eventual 
relationship between D/D, -735T/T, -786C/C and 
-1562 C/T genotypes and mortality. Interestingly, 8 
of 15 patients (53% and equal to 44% of all patients) 
with D/D genotype died, while  none of the 3 patients 
with D/I and I/I genotypes died. By comparing these 
data, no significant difference was found (8 vs 7 and 
0 vs 3, table 2x2 Fisher’s exact test).  Furthermore, 5 
of the 8 dead patients (equal to 33% of the 15 patients 
and 28% of all patients) were also carriers of -735T/
T MMP-2, -1562T/T MMP-9 and -786T/T eNOs 
genotypes. In searching a high genetic risk profile, we 
also assessed the frequency of DACE/-735TMMP-
2/-1562TMMP-9/ -736CeNOs high risk genotype in 
patients and controls. By comparing this frequency 
with that of other combinations, the frequency of this 
high risk genotype was significantly overrepresented 
in patients compared to controls (p=0.001 by c2 
test, 2x2 table; data not shown). Patients with high 
risk genotype showed significant associations with 
microscopic aorta wall alterations compared to 
controls (p=0.02 for elastic fragmentation of grade II 
and III; p=0.002 for cystic necrosis; p=0.01 plurifocal 
apoptosis; p=0.003 for severe MMP-9 amount and 
p=0.03 for inflammatory infiltrate, by c2 test and 
appropriate tables, data not shown). In addition, they 
also had a significant association with hypertension 
(p=0.01, by c2 test and appropriate tables, data not 
shown). Interestingly, 9 of these patients were D/D 
carriers. 
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